FDAFDA · Food and drugs·Recall number D-0105-2021
DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05
Published December 2, 2020 · Recall initiated: November 17, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: trace amounts of octreotide found during testing
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DOXORUBICIN HYDROCHLORIDE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Batch: 6120525, exp 11/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.